Extended Follow-up of Myeloablative, HLA-Matched Allogeneic BMT with High-Dose, Post-Transplantation Cyclophosphamide (PTCy) As Sole GVHD Prophylaxis: Favorable Outcomes Despite Low Incidence of Chronic GVHD

被引：0
|
作者：
Kanakry, Christopher G. [1 ]
Tsai, Hua-Ling [1 ]
Bolanos-Meade, Javier [1 ]
Smith, B. Douglas [1 ]
Gojo, Ivana [1 ]
Kasamon, Yvette L. [1 ]
Kanakry, Jennifer A. [1 ]
Zahurak, Marianna [1 ]
Fuchs, Ephraim J. [1 ]
Jones, Richard J. [1 ]
Luznik, Leo [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2014年 / 20卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2013.12.027
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
23
引用
收藏
页码：S37 / S37
页数：1
相关论文
共 15 条
  • [1] Post-Transplantation High Dose Cyclophosphamide As Gvhd Prophylaxis in 9/10 HLA-Matched Unrelated Donors Hematopoietic Stem Cell Transplantation
    Mehta, Rohtesh S.
    Saliba, Rima M.
    Chen, Julianne
    Rondon, Gabriela
    Hammerstrom, Aimee E.
    Alousi, Amin M.
    Qazilbash, Muzaffar H.
    Bashir, Qaiser
    Ahmed, Sairah
    Popat, Uday R.
    Hosing, Chitra M.
    Khouri, Issa F.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Ciurea, Stefan O.
    [J]. BLOOD, 2015, 126 (23)
  • [2] Low Incidence of Severe Mucositis After Myeloablative, HLA-Matched Bone Marrow Transplantation and High Dose, Post-Transplantation Cyclophosphamide
    Ying, Wendy
    Douglas, Tracy T.
    Durakovic, Nadira
    Brovitz-Palmer, Sallie
    Thomas, Lindsey Lombardi
    Jones, Richard J.
    Luznik, Leo
    Fuchs, Ephraim J.
    [J]. BLOOD, 2011, 118 (21) : 408 - 408
  • [3] Post-transplantation high-dose cyclophosphamide (Cy) is effective single agent GVHD prophylaxis that permits prompt immune reconstitution after myeloablative HLA matched related and unrelated bone marrow transplantation (BMT)
    Luznik, L.
    Fuchs, E. J.
    Chen, A. R.
    Kaup, M.
    Bright, E. C.
    Bolanos-Meade, J.
    Hess, A. D.
    Jones, R. J.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 4 - 4
  • [4] Post-transplant high-dose cyclophosphamide (PTCy) is an effective GVHD prophylaxis after unrelated HLA-matched (8/8) and mismatched (7/8) peripheral blood allogeneic stem cell transplantation
    Martinez, C.
    Kwon, M.
    Pascual-Cascon, M. J.
    Rovira, M.
    Fernandez-Aviles, F.
    Gutierrez, G.
    Suarez-Lledo, M.
    Isola, I.
    Urbano-Ispizua, A.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 : S172 - S173
  • [5] SECONDARY SYSTEMIC IMMUNOSUPPRESSANTS (SSI) AFTER MYELOABLATIVE HLA MATCHED RELATED AND UNRELATED BONE MARROW TRANSPLANTATION (BMT) USING HIGH DOSE CYCLOPHOSPHAMIDE (HICY) AS SOLE GVHD PROPHYLAXIS
    Durakovic, N.
    Meade, Bolanos J.
    Zahurak, M.
    Kowalski, J.
    Fuchs, E. J.
    Jones, R. J.
    Luznik, L.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S161 - S162
  • [6] High-dose cyclophosphamide for GvHD prophylaxis after HLA-matched or haplo-identical allogeneic haematopoietic stem cell transplantation: a single-centre experience
    Fedele, R.
    Messina, G.
    Moscato, T.
    Console, G.
    Martino, M.
    Massara, E.
    Cuzzola, M.
    Cannata, M. C.
    Pontari, A.
    Meliado, A.
    Irrera, G.
    Iacopino, P.
    [J]. BONE MARROW TRANSPLANTATION, 2011, 46 : S118 - S119
  • [7] Post-transplantation high-dose cyclophosphamide (Cy) is effective single agent GVHD prophylaxis that permits prompt immune reconstitution after myeloalblative HLA matched related and unrelated bone marrow transplantation (BMT).
    Leo, Luznik
    Allen, Chen R.
    Michele, Kaup
    Emilie, Bright C.
    Javier, Bolanos-Meade
    Christopher, Thorburn J.
    Ferdynand, Kos
    Allan, Hess D.
    Richard, Jones J.
    Ephraim, Fuchs J.
    [J]. BLOOD, 2006, 108 (11) : 818A - 819A
  • [8] GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation
    Dachy, Francois
    Furst, Sabine
    Calmels, Boris
    Pagliardini, Thomas
    Harbi, Samia
    Bouchacourt, Benjamin
    Calleja, Anne
    Lemarie, Claude
    Collignon, Aude
    Morel, Guillaume
    Legrand, Faezeh
    Bekrieva, Elena
    Granata, Angela
    Weiller, Pierre Jean
    Chabannon, Christian
    Schiano, Jean Marc
    Vey, Norbert
    Blaise, Didier
    Devillier, Raynier
    [J]. BONE MARROW TRANSPLANTATION, 2023, 58 (11) : 1179 - 1181
  • [9] GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation
    François Dachy
    Sabine Furst
    Boris Calmels
    Thomas Pagliardini
    Samia Harbi
    Benjamin Bouchacourt
    Anne Calleja
    Claude Lemarie
    Aude Collignon
    Guillaume Morel
    Faezeh Legrand
    Elena Bekrieva
    Angela Granata
    Pierre Jean Weiller
    Christian Chabannon
    Jean Marc Schiano
    Norbert Vey
    Didier Blaise
    Raynier Devillier
    [J]. Bone Marrow Transplantation, 2023, 58 : 1179 - 1181
  • [10] High-dose posttransplantation cyclophosphamide (PTCy) plus tacrolimus for HLA-identical 10/10 unrelated donor allogeneic transplantation is associated to a low risk of GVHD: experience of a single-center
    Jorge, Sofia
    Suarez-Lledo, Maria
    Gutierrez-Garcia, Gonzalo
    Fernandez-Aviles, Francesc
    Rosinol, Laura
    Gerardo Rodriguez-Lobato, Luis
    Solano, Teresa
    Urbano-Ispizua, Alvaro
    Rovira, Montserrat
    Martinez, Carmen
    [J]. BONE MARROW TRANSPLANTATION, 2018, 53 : 420 - 421
12